Balyasny Asset Management
IMMU

Balyasny Asset Management’s Immunomedics Inc IMMU Stock Holding History

Balyasny Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-352,800
Closed -$30M – 1877
2020
Q3 		$30M Buy
+352,800
New +$17.8M 0.22% 120
2020
Q1 		– Sell
-100,000
Closed -$2.12M – 1659
2019
Q4 		$2.12M Buy
+100,000
New +$1.76M 0.01% 748

Balyasny Asset Management's IMMU Position: Q4 2020 in Review

Balyasny Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 951,165 shares — an estimated $80.9M sold.

Balyasny Asset Management first reported a position in IMMU in Q3 2015 and held it in 10 quarters. The position peaked at $80.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Balyasny Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 951,165 Immunomedics Inc shares in Q4 2020, an estimated $80.9M.
  • Balyasny Asset Management first reported a position in Immunomedics Inc in Q3 2015 and held it in 10 quarters.
  • Balyasny Asset Management's Immunomedics Inc position peaked at $80.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Balyasny Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.